DUBLIN, Sept. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its ...
The US Food and Drug Administration (FDA) has approved the MiniMed 770G (Medtronic) automated insulin delivery system for children aged 2 to 6 years. The 770G will also be available to older children ...
Medtronic’s MiniMed 770G System has landed FDA clearance for its hybrid closed-loop system, marking the first time an automated insulin delivery system was greenlighted for young children with Type 1 ...
The FDA has approved the latest automated artificial pancreas system from Medtronic, the MiniMed 770G, for adults and children with Type 1 diabetes as young as 2 years old. This makes the hybrid, ...
Testing blood sugar frequently and administering insulin as needed throughout the day isn’t easy, especially if the individual with diabetes is a young child who can’t do it on their own yet. Now, ...
A Brisbane diabetes patient has become the first in the world to be treated with a “life-changing” new insulin pump system. The pump, which is the only technology of its type in Australia, measures ...
Please provide your email address to receive an email when new articles are posted on . All Medtronic MiniMed 600 and 700 series insulin pumps have been recalled due to an increased risk for short ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results